Germany starts neuroblastoma screening:
This article was originally published in Clinica
Executive Summary
Six German Lander are to start testing children this year for neuroblastomas - malignant brain tumours which account for 5% of all infant cancers. All parents of one-year-olds will be given urine test strips to be laid in the nappy and then sent to diagnostic laboratories; some 400,000 children per year will be tested. The survival rate following early diagnosis of a neuroblastoma is about 80%. Some 80% of all neuroblastomas occur between the ages of one and ten.
You may also be interested in...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.